Der­mi­ra sweeps PhI­II pso­ri­a­sis stud­ies for Cimzia as ri­vals threat­en an­oth­er en­try

Der­mi­ra has wrapped the third and fi­nal pso­ri­a­sis study of Cimzia, which the biotech says cleared the fi­nal hur­dles in the lead up to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA